Genfit SA (GNFT)
5.17
-0.75
(-12.67%)
USD |
NASDAQ |
May 31, 16:00
5.16
-0.01
(-0.19%)
After-Hours: 20:00
Genfit Accounts Receivable (Quarterly): 20.48M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.48M |
June 30, 2023 | 3.029M |
December 31, 2022 | 3.419M |
June 30, 2022 | 0.7751M |
December 31, 2021 | 8.193M |
June 30, 2021 | 16.47M |
December 31, 2020 | 0.9754M |
June 30, 2020 | 0.343M |
December 31, 2019 | 0.2319M |
June 30, 2019 | 3.429M |
December 31, 2018 | 0.0286M |
June 30, 2018 | 0.0705M |
June 30, 2018 | 0.0705M |
December 31, 2017 | 0.0732M |
June 30, 2017 | 0.0927M |
June 30, 2017 | 0.0927M |
December 31, 2016 | 0.0856M |
June 30, 2016 | 0.1157M |
June 30, 2016 | 0.1157M |
Date | Value |
---|---|
December 31, 2015 | 0.1891M |
June 30, 2015 | 0.1256M |
June 30, 2015 | 0.1256M |
December 31, 2014 | 0.529M |
June 30, 2014 | 0.1132M |
June 30, 2014 | 0.1132M |
December 31, 2013 | 0.2237M |
June 30, 2013 | 0.1551M |
June 30, 2013 | 0.1551M |
December 31, 2012 | 0.1428M |
June 30, 2012 | 0.886M |
June 30, 2012 | 0.886M |
December 31, 2011 | 0.9495M |
June 30, 2011 | 1.049M |
June 30, 2011 | 1.049M |
December 31, 2010 | 0.1258M |
June 30, 2010 | 0.1861M |
December 31, 2009 | 0.0865M |
June 30, 2009 | 0.8459M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.2319M
Minimum
Dec 2019
20.48M
Maximum
Dec 2023
5.735M
Average
3.224M
Median
Accounts Receivable (Quarterly) Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 16.04M |
Biophytis SA | 0.3283M |
Edap TMS SA | 18.37M |
Adaptimmune Therapeutics PLC | 8.404M |